SCHEMBL3645935

SCHEMBL3645935

COCCSc1ccc(C(=O)O)cc1.COCCSc1ccc(C(=O)OC)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.49
MAPT P10636 4/20 0.49
ALDH1A1 P00352 4/20 0.46
KMT2A Q03164 2/20 0.46
TSHR P16473 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
NPC1 O15118 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
CA12 O43570 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
LOXL2 Q9Y4K0 1/20 0.44
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4414189 0.94 MAPT (0.55) RAB9AMAPTALDH1A1KMT2ATSHR
SCHEMBL1018873 0.92 CA1 (0.47) RAB9AALDH1A1TSHRNPC1SMN1; SMN2
SCHEMBL7611290 0.80 MAPT (0.53) RAB9AMAPTALDH1A1KMT2ATSHR
SCHEMBL27555709 0.79 TSHR (0.70) RAB9AMAPTALDH1A1KMT2ATSHR
Terephthalic Acid SCHEMBL4349174 0.79 TSHR (0.70) RAB9AMAPTALDH1A1KMT2ATSHR
Terephthalic Acid SCHEMBL18394717 0.79 TSHR (0.70) RAB9AMAPTALDH1A1KMT2ATSHR
SCHEMBL63466 0.79 TSHR (0.70) RAB9AMAPTALDH1A1KMT2ATSHR
Terephthalic Acid SCHEMBL8811649 0.79 TSHR (0.70) RAB9AMAPTALDH1A1KMT2ATSHR
SCHEMBL10366613 0.79 ALDH1A1 (0.52) RAB9AMAPTALDH1A1KMT2ATSHR
SCHEMBL6617469 0.79 MAPT (0.51) RAB9AMAPTALDH1A1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2188257-A2 SULFOXIMINE DERIVATIVES AS FACTOR XA INHIBITORS Cadila Healthcare Limited (IN) 2010-05-26 EP disclosed
WO-2009053999-A2 SULFOXIMINE DERIVATIVES AS FACTOR XA INHIBITORS CADILA HEALTHCARE LIMITED (IN) 2009-04-30 WO disclosed